Danielle Brill analyst RAYMOND JAMES

Currently out of the existing stock ratings of Danielle Brill, 151 are a BUY (80.75%), 31 are a HOLD (16.58%), 5 are a SELL (2.67%).

Danielle Brill

Work Performance Price Targets & Ratings Chart

Analyst Danielle Brill, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 45.64% that have a potential upside of 28.99% achieved within 155 days.

Danielle Brill’s has documented 347 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on QURE, Uniqure NV at 10-Dec-2024.

Wall Street Analyst Danielle Brill

Analyst best performing recommendations are on AGIO (AGIOS PHARM).
The best stock recommendation documented was for XLRN (ACCELERON PHARMA) at 1/8/2020. The price target of $73 was fulfilled within 20 days with a profit of $19.46 (36.35%) receiving and performance score of 18.17.

Average potential price target upside

ACAD ACADIA Pharmaceuticals AGIO Agios Pharm ARGX argenx NV ADR FGEN FibroGen GBT Global Blood Therapeutics IMVT Immunovant  PASG Passage Bio PTCT PTC Therapeutics SAGE Sage Therapeutic SRPT Sarepta Therapeutics XLRN Acceleron Pharma HRMY Harmony Biosciences Holdings NBIX Neurocrine Biosciences QURE Uniqure NV MOR MorphoSys AG ADR ZGNX Zogenix MNTA Momenta Pharmaceuticals ALKS Alkermes Plc XENE Xenon Pharmaceuticals ALDR Alder BioPharmaceuticals GLYC GlycoMimetics BIIB Biogen VRTX Vertex Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$28

$8.4 (42.86%)

$28

4 days ago
(27-Feb-2025)

25/37 (67.57%)

$8.66 (44.78%)

486

Buy

$27

$7.4 (37.76%)

$27

4 days ago
(27-Feb-2025)

7/21 (33.33%)

$7.66 (39.61%)

118

Buy

$28

$8.4 (42.86%)

$28

4 days ago
(27-Feb-2025)

0/6 (0%)

$8.66 (44.78%)

Hold

$22

$2.4 (12.24%)

$24

20 days ago
(11-Feb-2025)

16/21 (76.19%)

$3.51 (18.98%)

174

Hold

$20

$0.4 (2.04%)

$25

2 months ago
(03-Jan-2025)

5/6 (83.33%)

$1.59 (8.64%)

172

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Danielle Brill is most bullish on?

Potential upside of $43.25 has been obtained for SRPT (SAREPTA THERAPEUTICS)

Which stock is Danielle Brill is most reserved on?

Potential downside of -$19.7 has been obtained for ARGX (ARGENX NV ADR)

What Year was the first public recommendation made by Danielle Brill?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?